$2.08
-0.16 (-7.14%)
Open$2.19
Previous Close$2.24
Day High$2.31
Day Low$2.07
52W High$38.58
52W Low$16.23
Volume—
Avg Volume691.8K
Market Cap140.64M
P/E Ratio16.32
EPS$1.65
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,361.5% upside
Current
$2.08
$2.08
Target
$30.40
$30.40
$22.94
$30.40 avg
$39.68
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 51.03M | 53.29M | 43.77M |
| Net Income | -10,998,457 | -9,463,863 | -8,925,272 |
| Profit Margin | -21.6% | -17.8% | -20.4% |
| EBITDA | -12,398,986 | -11,859,784 | -9,126,722 |
| Free Cash Flow | -10,819,178 | -9,841,834 | -11,921,306 |
| Rev Growth | +21.4% | -6.8% | -0.6% |
| Debt/Equity | 0.21 | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |